Product Information
TRYPTYR 0.003% EYE DROP is a brand product labeled by Alcon Laboratories, Inc., priced at $14.0864 per EA under NDC 00065859502. Its NADAC has been published 33 times since Feb 18, 2026.
FDA first approved this application on May 28, 2025.
Strength
.03 mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065859502
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC; TOPICAL
Effective Date
9/23/2026
Active Ingredients
ACOLTREMONApproval Type
New Drug (NDA)
FDA Application
NDA217370FDA Approved
5/28/2025
On Market Since
7/23/2025
Price Statistics
The NADAC for TRYPTYR 0.003% EYE DROP has been published 33 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.0864 per EA |
|---|---|
| All-time high | $14.0955 (Sep 16, 2026) |
| All-time low | $14.0678 (Feb 18, 2026) |
| 52-week high | $14.0955 |
| 52-week low | $14.0678 |
| Median price | $14.0819 |
| Average price | $14.0837 |
| Largest weekly change | +0.1% (Jun 17, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acoltremon market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acoltremon market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRYPTYR 0.003% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TRYPTYR 0.003% EYE DROP, manufactured by Alcon Laboratories, Inc., is $14.0864 per EA (NDC 00065859502), effective Sep 30, 2026.
How has the price of TRYPTYR 0.003% EYE DROP changed over time?
Over the history we have for it, the NADAC for TRYPTYR 0.003% EYE DROP has held within roughly two percent of its current level. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for TRYPTYR 0.003% EYE DROP?
Since Feb 18, 2026, the NADAC for TRYPTYR 0.003% EYE DROP has ranged from a low of $14.0678 (Feb 18, 2026) to a high of $14.0955 (Sep 16, 2026), with a median of $14.0819 per EA.
Are there cheaper alternatives to TRYPTYR 0.003% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of TRYPTYR 0.003% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRYPTYR 0.003% EYE DROP?
TRYPTYR 0.003% EYE DROP (NDC 00065859502) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.